Normal view MARC view ISBD view

Incidence of unanticipated uterine pathology at the time of minimally invasive abdominal sacrocolpopexy.

MedStar author(s):

1553-4650

Name of journal: Journal of minimally invasive gynecologyAbstract: CONCLUSION: The risk of unanticipated uterine pathologic findings during minimally invasive sacrocolpopexy to treat pelvic organ prolapse is low. Copyright 2014 AAGL. Published by Elsevier Inc. All rights reserved.DESIGN: Retrospective case series (Canadian Task Force classification III).INTERVENTIONS: Concurrent hysterectomy and minimally invasive sacrocolpopexy.MEASUREMENTS AND MAIN RESULTS: We measured the incidence of clinically important uterine disease at minimally invasive sacrocolpopexy. A total of 324 women underwent concurrent hysterectomy and minimally invasive sacrocolpopexy. Their mean age was 56.1 years, and body mass index was 26.9 kg/m(2). Sixty-four percent were postmenopausal. Only 3 patients (0.92%) had abnormal uterine pathologic findings. No significant differences were noted in age, body mass index, or parity between the women with normal and abnormal uterine pathologic findings. None of the 3 women reported abnormal uterine bleeding before surgery. All lesions were premalignant and focal. No invasive carcinomas were identified. No patients required further follow-up or treatment of abnormal pathologic findings.PATIENTS: Women undergoing laparoscopic or robotically assisted sacrocolpopexy with hysterectomy.SETTING: Four institutions in the United States.STUDY OBJECTIVE: To determine the incidence of unanticipated uterine pathologic findings in women undergoing hysterectomy concomitant with minimally invasive sacrocolpopexy.All authors: Andy UU, Gutman RE, Harvie HS, Kane S, Lowenstein L, Nosti PA, White DDigital Object Identifier:

http://dx.doi.org/10.1016/j.jmig.2013.07.008

Date added to catalog: 2014-09-12

Holdings ( 1 )
Title notes ( 8 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article		Available		23911564

CONCLUSION: The risk of unanticipated uterine pathologic findings during minimally invasive sacrocolpopexy to treat pelvic organ prolapse is low. Copyright 2014 AAGL. Published by Elsevier Inc. All rights reserved.

DESIGN: Retrospective case series (Canadian Task Force classification III).

INTERVENTIONS: Concurrent hysterectomy and minimally invasive sacrocolpopexy.

MEASUREMENTS AND MAIN RESULTS: We measured the incidence of clinically important uterine disease at minimally invasive sacrocolpopexy. A total of 324 women underwent concurrent hysterectomy and minimally invasive sacrocolpopexy. Their mean age was 56.1 years, and body mass index was 26.9 kg/m(2). Sixty-four percent were postmenopausal. Only 3 patients (0.92%) had abnormal uterine pathologic findings. No significant differences were noted in age, body mass index, or parity between the women with normal and abnormal uterine pathologic findings. None of the 3 women reported abnormal uterine bleeding before surgery. All lesions were premalignant and focal. No invasive carcinomas were identified. No patients required further follow-up or treatment of abnormal pathologic findings.

PATIENTS: Women undergoing laparoscopic or robotically assisted sacrocolpopexy with hysterectomy.

SETTING: Four institutions in the United States.

STUDY OBJECTIVE: To determine the incidence of unanticipated uterine pathologic findings in women undergoing hysterectomy concomitant with minimally invasive sacrocolpopexy.

English